Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Ford-Siltz LA"'
Autor:
Ford-Siltz LA; Division of Viral Products, CBER, FDA, Silver Spring, Maryland, USA., Tohma K; Division of Viral Products, CBER, FDA, Silver Spring, Maryland, USA., Kihn K; University of Maryland School of Pharmacy, Baltimore, Maryland, USA., Kendra JA; Division of Viral Products, CBER, FDA, Silver Spring, Maryland, USA., Deredge D; University of Maryland School of Pharmacy, Baltimore, Maryland, USA., Wintrode P; University of Maryland School of Pharmacy, Baltimore, Maryland, USA., Gao Y; Division of Viral Products, CBER, FDA, Silver Spring, Maryland, USA., Parra GI; Division of Viral Products, CBER, FDA, Silver Spring, Maryland, USA.
Publikováno v:
Microbiology spectrum [Microbiol Spectr] 2024 Oct 28, pp. e0114324. Date of Electronic Publication: 2024 Oct 28.
Autor:
Pilewski KA; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Ford-Siltz LA; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Tohma K; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Kendra JA; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Landivar M; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Parra GI; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Oct 16; Vol. 230 (4), pp. 982-994.
Publikováno v:
Emerging infectious diseases [Emerg Infect Dis] 2024 May; Vol. 30 (5), pp. 1026-1029.
Autor:
Parra GI; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Tohma K; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Ford-Siltz LA; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Eguino P; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Kendra JA; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Pilewski KA; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Gao Y; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
Journal of virology [J Virol] 2023 Feb 28; Vol. 97 (2), pp. e0171622. Date of Electronic Publication: 2023 Jan 23.
Autor:
Ford-Siltz LA; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States., Tohma K; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States., Alvarado GS; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States., Kendra JA; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States., Pilewski KA; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States., Crowe JE Jr; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.; Department of Pediatrics and Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, United States., Parra GI; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Oct 25; Vol. 13, pp. 1040836. Date of Electronic Publication: 2022 Oct 25 (Print Publication: 2022).
Autor:
Tohma K; Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Building 52/72, Room 1309, Silver Spring, MD 20993, USA., Ford-Siltz LA; Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Building 52/72, Room 1309, Silver Spring, MD 20993, USA., Kendra JA; Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Building 52/72, Room 1309, Silver Spring, MD 20993, USA., Parra GI; Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Building 52/72, Room 1309, Silver Spring, MD 20993, USA. Electronic address: gabriel.parra@fda.hhs.gov.
Publikováno v:
Cell reports [Cell Rep] 2022 Apr 12; Vol. 39 (2), pp. 110689.
Autor:
Ford-Siltz LA; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Wales S; Center for Food Safety and Applied Nutrition, Food and Drug Administration, Laurel, Maryland, USA., Tohma K; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Gao Y; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Parra GI; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2022 Apr 01; Vol. 225 (7), pp. 1205-1214.
Autor:
Tohma K; Division of Viral Products, CBER, FDA, Silver Spring, MD, USA., Saito M; Department of Virology, Tohoku University Graduate School of Medicine, Sendai, Japan., Pajuelo MJ; Department of Cellular and Molecular Sciences, Faculty of Sciences, Universidad Peruana Cayetano Heredia, Lima, Peru., Mayta H; Department of Cellular and Molecular Sciences, Faculty of Sciences, Universidad Peruana Cayetano Heredia, Lima, Peru., Zimic M; Department of Cellular and Molecular Sciences, Faculty of Sciences, Universidad Peruana Cayetano Heredia, Lima, Peru., Lepore CJ; Division of Viral Products, CBER, FDA, Silver Spring, MD, USA., Ford-Siltz LA; Division of Viral Products, CBER, FDA, Silver Spring, MD, USA., Gilman RH; Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA., Parra GI; Division of Viral Products, CBER, FDA, Silver Spring, MD, USA.
Publikováno v:
Emerging microbes & infections [Emerg Microbes Infect] 2021 Dec; Vol. 10 (1), pp. 1717-1730.
Autor:
Tohma K; Division of Viral Products, CBER, FDA, Silver Spring, Maryland, United States of America., Lepore CJ; Division of Viral Products, CBER, FDA, Silver Spring, Maryland, United States of America., Martinez M; Division of Viral Products, CBER, FDA, Silver Spring, Maryland, United States of America.; IICS, National University of Asuncion, Asuncion, Paraguay., Degiuseppe JI; INEI-ANLIS, Ministry of Health, Buenos Aires, Argentina., Khamrin P; Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Saito M; Department of Virology, Tohoku University Graduate School of Medicine, Sendai, Japan., Mayta H; Department of Cellular and Molecular Sciences, Faculty of Sciences, Universidad Peruana Cayetano Heredia, Lima, Peru., Nwaba AUA; Division of Viral Products, CBER, FDA, Silver Spring, Maryland, United States of America., Ford-Siltz LA; Division of Viral Products, CBER, FDA, Silver Spring, Maryland, United States of America., Green KY; Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, Maryland, United States of America., Galeano ME; IICS, National University of Asuncion, Asuncion, Paraguay., Zimic M; Department of Cellular and Molecular Sciences, Faculty of Sciences, Universidad Peruana Cayetano Heredia, Lima, Peru., Stupka JA; INEI-ANLIS, Ministry of Health, Buenos Aires, Argentina., Gilman RH; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Maneekarn N; Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Ushijima H; Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan., Parra GI; Division of Viral Products, CBER, FDA, Silver Spring, Maryland, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2021 Jul 13; Vol. 17 (7), pp. e1009744. Date of Electronic Publication: 2021 Jul 13 (Print Publication: 2021).
Autor:
Kendra JA; Division of Viral Products, Food and Drug Administration, Silver Spring, MD 20993., Tohma K; Division of Viral Products, Food and Drug Administration, Silver Spring, MD 20993., Ford-Siltz LA; Division of Viral Products, Food and Drug Administration, Silver Spring, MD 20993., Lepore CJ; Division of Viral Products, Food and Drug Administration, Silver Spring, MD 20993., Parra GI; Division of Viral Products, Food and Drug Administration, Silver Spring, MD 20993 gabriel.parra@fda.hhs.gov.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Mar 16; Vol. 118 (11).